ANIK

Anika Therapeutics, Inc. $20.86 1M -5.3% 3M +41.7% YTD +123.1% as of 2026-09-11
+Watchlist

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings beat miss  ·  ring before open after close  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.6%
Next 1 week
+0.7%
Next 1 month
+0.3%
Seasonality
Bullish window historically
Next 30 days (to Oct 14): +3.5% median, 66% of the last 32 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 32
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.58%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.67 -0.1% · Seasonal tilt +0.4%
$2M/day volume 50% volatility +148% 1-year -72% from ATH
52-week range · 86% of the way up · -9% from the high
$8.44$22.88

Congressional trades in ANIK Full tracker →

1 member · 5 buys / 3 sells · $71K–$205K disclosed · latest filing Aug 26, 2021.

SELL TM Tom Malinowski · traded Jul 29, 2019 $1K–$15K
BUY TM Tom Malinowski · traded Aug 1, 2019 $50K–$100K
SELL TM Tom Malinowski · traded Oct 29, 2019 $1K–$15K
SELL TM Tom Malinowski · traded Jan 28, 2020 $1K–$15K
BUY TM Tom Malinowski · traded Feb 27, 2020 $1K–$15K
BUY TM Tom Malinowski · traded Feb 28, 2020 $1K–$15K
BUY TM Tom Malinowski · traded Feb 26, 2020 $15K
BUY TM Tom Malinowski · traded Mar 2, 2020 $1K–$15K

Earnings Full history →

Next report 2026-11-04 (Wednesday, before open, in 51 days) · EPS est. 0.17.

1-day std dev
13.1%
Finished up
45%
Biggest pop
+35.2%
Biggest drop
-30.7%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.